telehealth.helpFind my match

Home Videos 7 min explainer

Semaglutide vs. tirzepatide: what did the trials measure, and what does each cost per month?

7 min · Data checked Nov 8, 2026 · Narrated by an AI voice · General information, not medical advice.

In the one head-to-head trial (SURMOUNT-5), people on tirzepatide lost 20.2% of their weight on average at 72 weeks vs. 13.7% on semaglutide. In the programs we compare, compounded semaglutide starts at $69 a month (SnagRx, checked Nov 7, 2026) and compounded tirzepatide at $96 a month on a 12-month plan (yourEra, checked Nov 8, 2026).

In this video

  1. 0:00 Introduction
  2. 0:10 Two medicines, four brand names
  3. 1:09 What STEP 1 measured
  4. 2:01 What SURMOUNT-1 measured
  5. 2:49 The head-to-head trial
  6. 3:51 What a month costs
  7. 5:19 Cost per 1% lost
  8. 6:21 How to choose

Key numbers in this video

SURMOUNT-5 average loss at 72 weeks20.2% tirzepatide vs 13.7% semaglutideAronne et al., NEJM 2025; checked Nov 3, 2026
STEP 1 average loss (semaglutide 2.4 mg, 68 weeks)14.9%Wegovy label; checked Nov 3, 2026
SURMOUNT-1 average loss (tirzepatide 15 mg, 72 weeks)20.9%Zepbound label; checked Nov 3, 2026
Lowest compounded semaglutide$69/mo month to month (sale)SnagRx, checked Nov 7, 2026
Lowest compounded tirzepatide$96/mo on a 12-month planyourEra, checked Nov 8, 2026
Middle price of 17 programs$119 semaglutide / $185 tirzepatideChecked Nov 7-8, 2026

Read on each program's own site; dates as shown. Prices change: the full comparison has today's numbers.

Programs from this video, compared

How we pick and check programs

  1. Our pick for November 2026 · Money-back guarantee#1
    48% off your first month

    Lose weight or get your money back

    First month from$129/mosemaglutide welcome offer; tirzepatide from $169
    Visit LevelsRx Read our LevelsRx review
  2. Pills or shots#2
    Semaglutide from $99/mo

    Choose weekly shots or daily tablets; shots from $99/mo on the 12-month plan

    Semaglutide shots from$99/moon the 12-month plan; $199 month to month
    Visit BetterMe Rx Read our BetterMe Rx review
  3. Sale price locked in#3
    Pre-Black Friday sale: was $299

    Compounded semaglutide for $59 a month during its sale

    Semaglutide$59/moduring the pre-Black Friday sale (was $299); the page counts down to a price increase and says the sale price is locked in for life
    Visit SnagRx Read our SnagRx review

19 more programs are in the price tables above.

Transcript

What the video says as recorded, with data checked Nov 8, 2026. Programs, prices and counts are as of that date; the full comparison has today's list.

Introduction 0:00

Semaglutide or tirzepatide? In this video we look at what the main trials measured, and what each one costs per month in the programs we compare.

Two medicines, four brand names 0:10

First, the two medicines, and the brand names you will see on the box. Semaglutide acts on one gut hormone, GLP-1. It is sold as Wegovy for weight loss and Ozempic for type two diabetes. Tirzepatide acts on two, GLP-1 and GIP. It is sold as Zepbound and Mounjaro. So when people search tirzepatide versus Ozempic, or tirzepatide versus Wegovy, it is the same comparison as this one. Ozempic and Wegovy are both semaglutide. Online programs also sell compounded semaglutide and tirzepatide. They are made by a licensed compounding pharmacy and are not FDA approved. The trials in this video tested the brand-name versions, not the compounded ones. One more thing before the numbers. A trial result is an average across everyone in the study, measured at one point in time. It is what the study measured, not a promise for any one person.

What STEP 1 measured 1:09

Let's start with semaglutide, and its main weight-loss trial, called STEP one. STEP one tested semaglutide two point four milligrams a week, the Wegovy dose, for sixty-eight weeks. On average, people on semaglutide lost fourteen point nine percent of their body weight. People on placebo, in the same trial, lost two point four percent on average. The study also counted how many people reached each mark. Eighty-three point five percent lost at least five percent. Sixty-six point one percent lost at least ten. Forty-seven point nine percent lost fifteen, and thirty point two percent lost twenty percent or more. A follow-up of STEP one looked at people after they stopped. Within a year of stopping, they regained about two thirds of the weight they had lost. The lifestyle program stopped at the same time as the drug.

What SURMOUNT-1 measured 2:01

Now tirzepatide, and its main weight-loss trial, SURMOUNT one. SURMOUNT one ran for seventy-two weeks. In the fifteen milligram group, the highest dose on the Zepbound label, people lost twenty point nine percent of their body weight on average. On placebo, people lost three point one percent. Here are the same marks. Ninety point nine percent lost at least five percent. Eighty-three point five percent lost at least ten. Seventy point six percent lost fifteen, and fifty-six point seven percent lost twenty percent or more. Side by side, the tirzepatide trial measured the bigger average loss. But these were two separate trials, with different people and different lengths. To compare the drugs directly, you need a trial that tested both.

The head-to-head trial 2:49

That trial exists. It is called SURMOUNT five. Notice the lengths first. STEP one ran sixty-eight weeks. SURMOUNT one ran seventy-two. And the head-to-head trial, SURMOUNT five, also ran seventy-two weeks. SURMOUNT five randomized seven hundred fifty-one adults with obesity and without type two diabetes. It was open-label, so people knew which drug they took. Each group used the highest dose they tolerated. At seventy-two weeks, the tirzepatide group had lost twenty point two percent of body weight on average. The semaglutide group had lost thirteen point seven percent. So in the one direct comparison, the average gap was six and a half percentage points. That is what the study measured on the brand-name drugs. It does not tell you what any one person will lose. Both labels list nausea, diarrhea, vomiting and constipation among the most common side effects. The labels report stomach side effects most often while the dose is going up.

What a month costs 3:51

Now the money. What does each one cost per month in the programs we compare? These are compounded prices, read on each program's own site, and every row has its own check date. Brand-name Wegovy and Zepbound cost more. They have their own video. For compounded semaglutide, the lowest price in our list is SnagRx, at sixty-nine dollars a month, month to month. It is a pre-Black Friday sale price, down from two hundred ninety-nine dollars. For compounded tirzepatide, the lowest is yourEra, at ninety-six dollars a month. That price needs the twelve-month plan, billed up front: one thousand one hundred fifty-two dollars. Several semaglutide programs sit close to one hundred dollars a month. Read the plan length: most of these low prices need a twelve-month plan. For tirzepatide, the low end runs from ninety-six to one hundred seventy-seven dollars a month. SnagRx, at one hundred nineteen dollars on a sale price, is the lowest month-to-month price in this group. The middle price tells you more than the lowest one. Across the seventeen programs in each of our lists, the middle semaglutide price is one hundred nineteen dollars a month. For tirzepatide it is one hundred eighty-five. Programs that keep one price at every dose matter most for tirzepatide, because brand-name tirzepatide prices rise with the dose. Ask what you will pay at your full dose.

Cost per 1% lost 5:19

Our page on this topic does one more piece of math: the cost for each percent of body weight lost in the trials. Take the monthly price. Multiply it by the number of months the trial ran. Then divide by the average percent lost in that trial. Sixty-eight weeks is about fifteen point seven months. Seventy-two weeks is about sixteen point six months. At the lowest prices, semaglutide comes to about one thousand eighty-three dollars to the trial's end, or seventy-three dollars per percent. Tirzepatide comes to about one thousand five hundred ninety-five dollars, or seventy-six dollars per percent. At the middle prices, the gap is wider: about one hundred twenty-five dollars per percent for semaglutide, and one hundred forty-seven for tirzepatide. Treat this as a way to compare prices, not a forecast. It uses trial averages from the brand-name drugs, and it assumes one price at every dose. Your own result and dose path will be different.

How to choose 6:21

So how do people choose between the two? In short. Tirzepatide, if you want the drug with the larger average loss in the trials, or semaglutide has stopped working for you. Semaglutide, if the lowest monthly price matters most. Both come as tablets or drops at some of the programs we compare, not only as a shot. People also switch between the two, for example when their weight loss slows. The clinician in the program sets the starting dose of the new drug, based on what you take now. Whichever you pick, ask four things. Is the price month to month, or does it need a plan? Does it go up with the dose? Are you billed every month, or every four weeks? And are the visit and shipping included? We keep both price lists current, with a check date on every row. Compare semaglutide and tirzepatide programs side by side at telehealth.help.

Related